←Back to structures
term1_saliva_scaffold_14_prodigal-single.1__X__X__00039
Bact-Virterm1_saliva_scaffold_14_prodigal-single.1__X__X__00039
Identity
- Kingdom:
- phage
Quality
67.4
mean pLDDT
Cluster
Singleton — not in a non-trivial cluster
3D Structure
Domains
high = three domain segmentations agree, medium = two domain segmentations agree. Numbered high-first then medium, N→C within each tier.
D1
high
residues 109-249
Domain cluster:
rep: MN270258.1__QGJ85309.1__X__00082__D64-191
CATH (43)
| Domain ID | Class ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 3ub1A01 | 3.10.450.540 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.78 | 64.0 | 6.60e-01 | 100.0% | 88.2% |
| 2i9wA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 51.0 | 4.72e-01 | 97.9% | 61.9% |
| 3rgaA01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 54.0 | 5.56e-01 | 100.0% | 88.0% |
| 6uioC01 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 47.0 | 5.44e-01 | 100.0% | 98.1% |
| 3a76A01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 56.0 | 5.68e-01 | 100.0% | 88.5% |
| 3robA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.67 | 54.0 | 5.64e-01 | 100.0% | 91.6% |
| 2fxtA00 | 3.10.450.240 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.67 | 60.0 | 5.40e-01 | 100.0% | 71.4% |
| 4l8oA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 54.0 | 5.19e-01 | 100.0% | 75.0% |
| 5cxoB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 52.0 | 5.36e-01 | 100.0% | 87.3% |
| 3fsdA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 52.0 | 5.59e-01 | 100.0% | 97.5% |
| 2cw9A00 | 3.10.450.240 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 57.0 | 5.21e-01 | 100.0% | 72.5% |
| 2chcC00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 52.0 | 4.99e-01 | 100.0% | 74.2% |
| 3soyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 55.0 | 5.50e-01 | 100.0% | 88.7% |
| 1a90A00 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 46.0 | 5.16e-01 | 100.0% | 95.4% |
| 1jkgA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.64 | 52.0 | 5.29e-01 | 100.0% | 87.1% |
| 4it7A00 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.64 | 45.0 | 5.02e-01 | 100.0% | 93.5% |
| 5ig0A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.64 | 53.0 | 5.52e-01 | 100.0% | 94.7% |
| 2rgqB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.64 | 52.0 | 5.37e-01 | 100.0% | 92.5% |
| 4gb5A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.63 | 55.0 | 5.43e-01 | 100.0% | 88.5% |
| 5i97C00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.63 | 56.0 | 5.70e-01 | 100.0% | 97.8% |
| 3kspA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.63 | 49.0 | 5.12e-01 | 100.0% | 90.7% |
| 3cnxA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.62 | 53.0 | 5.38e-01 | 100.0% | 93.5% |
| 1of5A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.62 | 52.0 | 5.06e-01 | 100.0% | 82.5% |
| 3grdA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.61 | 49.0 | 5.10e-01 | 99.3% | 90.2% |
| 3f7xA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.61 | 50.0 | 5.19e-01 | 100.0% | 91.7% |
| 2ch9A01 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.61 | 44.0 | 4.81e-01 | 100.0% | 92.0% |
| 3lh4A00 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.60 | 43.0 | 4.67e-01 | 100.0% | 88.7% |
| 2gexA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.60 | 49.0 | 4.88e-01 | 100.0% | 83.6% |
| 2rfrA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.60 | 52.0 | 5.11e-01 | 100.0% | 85.1% |
| 3er7B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.60 | 46.0 | 4.91e-01 | 98.6% | 93.5% |
| 1q42A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.59 | 54.0 | 5.21e-01 | 100.0% | 95.0% |
| 3e99A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.59 | 52.0 | 5.12e-01 | 100.0% | 89.9% |
| 3rgaA02 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.59 | 52.0 | 5.17e-01 | 100.0% | 90.5% |
| 4n6mB00 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.58 | 42.0 | 4.55e-01 | 100.0% | 91.4% |
| 2b1xB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.58 | 53.0 | 5.04e-01 | 100.0% | 88.0% |
| 1uliB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.56 | 52.0 | 4.82e-01 | 100.0% | 85.3% |
| 3ejvA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.56 | 52.0 | 4.99e-01 | 100.0% | 93.1% |
| 1lshA01 | 2.30.230.10 | Mainly Beta › Roll › Lipovitellin-phosvitin complex; beta-sheet shell regions › Lipovitellin; beta-sheet shell regions, chain A | 0.54 | 41.0 | 3.35e-01 | 79.4% | 66.2% |
| 4kwyA00 | 3.30.160.150 | Alpha Beta › 2-Layer Sandwich › Double Stranded RNA Binding Domain › Lipoprotein like domain | 0.53 | 40.0 | 4.13e-01 | 88.7% | 81.8% |
| 4kghA00 | 3.15.10.10 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › Bactericidal permeability-increasing protein; domain 1 | 0.53 | 44.0 | 3.96e-01 | 100.0% | 64.8% |
| 6a5gA01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.53 | 43.0 | 4.45e-01 | 100.0% | 91.9% |
| 2yfsA01 | 2.115.10.20 | Mainly Beta › 5 Propeller › Tachylectin-2; Chain A › Glycosyl hydrolase domain; family 43 | 0.51 | 42.0 | 2.96e-01 | 100.0% | 26.2% |
| 2w4yA00 | 2.40.160.220 | Mainly Beta › Beta Barrel › Porin › | 0.50 | 27.0 | 2.89e-01 | 100.0% | 57.4% |
ECOD (52)
| UID | F-ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 3399719 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.70 | 48.0 | 5.50e-01 | 98.6% | 94.3% |
| 3764790 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.69 | 44.0 | 5.28e-01 | 100.0% | 95.8% |
| 3641463 | 243.1.1.24 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › ARC6-like_IMS | 0.68 | 57.0 | 5.70e-01 | 100.0% | 88.3% |
| 1558628 | 243.1.1.15 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › T4BSS_DotI_IcmL | 0.68 | 59.0 | 6.02e-01 | 100.0% | 94.3% |
| 4419521 | 243.1.1.108 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2_YvbJ | 0.67 | 57.0 | 5.88e-01 | 100.0% | 94.8% |
| 3587488 | 243.1.1.5 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Tim44 | 0.66 | 56.0 | 5.46e-01 | 100.0% | 83.1% |
| 3562982 | 243.3.1.1 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cystatin | 0.66 | 46.0 | 5.07e-01 | 100.0% | 87.8% |
| 3217155 | 243.1.1.97 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF5382_N | 0.66 | 55.0 | 5.40e-01 | 100.0% | 82.0% |
| 4187684 | 243.3.1.1 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cystatin | 0.66 | 46.0 | 5.16e-01 | 99.3% | 91.8% |
| 3875088 | 243.3.1.1 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cystatin | 0.66 | 44.0 | 5.01e-01 | 100.0% | 88.9% |
| 3598427 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.65 | 56.0 | 5.67e-01 | 99.3% | 92.1% |
| 3278413 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.65 | 55.0 | 5.52e-01 | 100.0% | 89.3% |
| 3281242 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.65 | 52.0 | 5.44e-01 | 100.0% | 92.3% |
| 3207181 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.65 | 39.0 | 4.75e-01 | 87.2% | 93.3% |
| 3890249 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.65 | 44.0 | 5.05e-01 | 99.3% | 94.2% |
| 3690324 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.64 | 55.0 | 5.53e-01 | 100.0% | 91.4% |
| 3484327 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.64 | 46.0 | 5.07e-01 | 100.0% | 92.2% |
| 3729993 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.64 | 54.0 | 5.64e-01 | 100.0% | 98.5% |
| 4020255 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.64 | 59.0 | 4.93e-01 | 100.0% | 60.4% |
| 3703305 | 243.1.1.86 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2_MEX67 | 0.63 | 58.0 | 4.91e-01 | 100.0% | 85.7% |
| 3557003 | 243.3.1.1 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cystatin | 0.63 | 45.0 | 4.48e-01 | 100.0% | 70.0% |
| 4461362 | 243.3.1.1 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cystatin | 0.63 | 44.0 | 4.83e-01 | 100.0% | 87.8% |
| 3927804 | 243.3.1.1 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cystatin | 0.63 | 45.0 | 5.04e-01 | 100.0% | 95.4% |
| 3381153 | 243.1.1.24 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › ARC6-like_IMS | 0.62 | 55.0 | 5.53e-01 | 100.0% | 94.4% |
| 3914956 | 243.3.1.1 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cystatin | 0.62 | 45.0 | 5.01e-01 | 100.0% | 95.5% |
| 4244521 | 243.3.1.1 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cystatin | 0.62 | 45.0 | 4.87e-01 | 100.0% | 89.2% |
| 4968480 | 243.1.1.5 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Tim44 | 0.62 | 56.0 | 5.29e-01 | 100.0% | 81.8% |
| 3509929 | 243.3.1.1 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cystatin | 0.62 | 48.0 | 4.75e-01 | 100.0% | 76.0% |
| 3240204 | 243.3.1.1 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cystatin | 0.61 | 44.0 | 4.79e-01 | 100.0% | 89.6% |
| 1495426 | 243.1.1.14 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Mtr2 | 0.61 | 56.0 | 5.35e-01 | 100.0% | 88.5% |
| 4177164 | 243.3.1.1 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cystatin | 0.61 | 45.0 | 4.87e-01 | 100.0% | 90.0% |
| 3021721 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.61 | 56.0 | 4.64e-01 | 100.0% | 79.1% |
| 2980101 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.61 | 56.0 | 4.66e-01 | 100.0% | 80.4% |
| 3795495 | 243.3.1.1 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cystatin | 0.61 | 43.0 | 4.60e-01 | 100.0% | 85.0% |
| 3728831 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.60 | 55.0 | 5.37e-01 | 100.0% | 89.7% |
| 3577972 | 243.3.1.1 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cystatin | 0.60 | 45.0 | 4.77e-01 | 100.0% | 88.0% |
| 3773175 | 883.1.1.1 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP | 0.59 | 42.0 | 3.87e-01 | 100.0% | 56.2% |
| 4230734 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.59 | 47.0 | 4.54e-01 | 100.0% | 75.5% |
| 3727278 | 331.3.1.6 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › PRELI | 0.59 | 38.0 | 3.25e-01 | 98.6% | 41.9% |
| 3247363 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.58 | 45.0 | 4.87e-01 | 100.0% | 95.8% |
| 3870396 | 243.3.1.1 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cystatin | 0.58 | 41.0 | 4.53e-01 | 100.0% | 90.4% |
| 3629176 | 243.3.1.1 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cystatin | 0.58 | 39.0 | 4.36e-01 | 97.2% | 90.5% |
| 4015212 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.57 | 49.0 | 4.90e-01 | 99.3% | 89.7% |
| 3318131 | 9.3.1.4 ↗ | beta barrels › Lipocalins/Streptavidin › Quinohemoprotein amine dehydrogenase A chain, domain 3-like › Quinohemoprotein amine dehydrogenase A chain, domain 3-like › DUF2921_N | 0.56 | 40.0 | 3.86e-01 | 100.0% | 63.6% |
| 3339862 | 9.3.1.4 ↗ | beta barrels › Lipocalins/Streptavidin › Quinohemoprotein amine dehydrogenase A chain, domain 3-like › Quinohemoprotein amine dehydrogenase A chain, domain 3-like › DUF2921_N | 0.54 | 40.0 | 3.66e-01 | 100.0% | 60.0% |
| 3450504 | 5084.1.1.27 ↗ | beta barrels › Outer membrane meander beta-barrels › OMPA-like › OMPA-like › DUF2921_N | 0.53 | 39.0 | 3.74e-01 | 100.0% | 64.8% |
| 3482245 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.52 | 46.0 | 4.58e-01 | 100.0% | 96.7% |
| 3434245 | 9.3.1.4 ↗ | beta barrels › Lipocalins/Streptavidin › Quinohemoprotein amine dehydrogenase A chain, domain 3-like › Quinohemoprotein amine dehydrogenase A chain, domain 3-like › DUF2921_N | 0.52 | 40.0 | 3.79e-01 | 100.0% | 67.6% |
| 3364483 | 9.2.1.4 ↗ | beta barrels › Lipocalins/Streptavidin › Avidin/Streptavidin › Avidin/Streptavidin › DUF2921_N | 0.52 | 42.0 | 3.85e-01 | 97.9% | 66.7% |
| 3402622 | 243.1.1.49 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF2358 | 0.52 | 45.0 | 4.60e-01 | 100.0% | 99.3% |
| 4609120 | 2.1.1.127 ↗ | beta barrels › OB-fold › Nucleic acid-binding protein › Nucleic acid-binding protein › tRNA_anti_2 | 0.51 | 27.0 | 3.32e-01 | 81.6% | 80.0% |
| 139113 | 883.1.1.3 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › JHBP | 0.50 | 46.0 | 3.92e-01 | 100.0% | 62.6% |
D2
high
residues 269-392
Domain cluster:
representative
CATH (33)
| Domain ID | Class ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 5bkaE01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 66.0 | 6.49e-01 | 98.4% | 97.7% |
| 1jkgB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 64.0 | 5.64e-01 | 99.2% | 83.9% |
| 3ub1A01 | 3.10.450.540 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 64.0 | 6.20e-01 | 98.4% | 89.0% |
| 2cw9A00 | 3.10.450.240 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 66.0 | 5.68e-01 | 100.0% | 82.4% |
| 6ihjC00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 64.0 | 5.79e-01 | 100.0% | 87.5% |
| 2c4iA01 | 2.40.128.30 | Mainly Beta › Beta Barrel › Lipocalin › Avidin-like | 0.70 | 43.0 | 4.43e-01 | 97.6% | 64.4% |
| 7c5wA01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 62.0 | 5.86e-01 | 96.0% | 99.3% |
| 7c5yA02 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 62.0 | 5.79e-01 | 96.0% | 99.3% |
| 1q42A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 64.0 | 5.82e-01 | 98.4% | 95.0% |
| 3soyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 63.0 | 5.99e-01 | 98.4% | 90.8% |
| 2bmoB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 63.0 | 5.37e-01 | 100.0% | 79.4% |
| 2ckfB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.67 | 62.0 | 5.55e-01 | 100.0% | 90.0% |
| 3robA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 60.0 | 5.97e-01 | 98.4% | 93.9% |
| 4gb5A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 60.0 | 5.66e-01 | 98.4% | 89.9% |
| 3d9rB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 60.0 | 5.86e-01 | 98.4% | 94.0% |
| 3hx8A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 60.0 | 5.94e-01 | 97.6% | 94.5% |
| 3bb9B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 59.0 | 5.96e-01 | 97.6% | 97.6% |
| 6uioC01 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 51.0 | 5.59e-01 | 99.2% | 100.0% |
| 2imjD01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 55.0 | 5.26e-01 | 98.4% | 79.6% |
| 3f9sB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 59.0 | 5.69e-01 | 97.6% | 89.4% |
| 5o46A00 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.64 | 50.0 | 5.27e-01 | 100.0% | 89.5% |
| 4it7A00 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.63 | 48.0 | 5.17e-01 | 100.0% | 94.4% |
| 3ehcB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.62 | 54.0 | 5.39e-01 | 96.0% | 89.8% |
| 5aigA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.62 | 51.0 | 5.16e-01 | 96.0% | 88.7% |
| 3kkgA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.62 | 56.0 | 5.37e-01 | 99.2% | 88.9% |
| 2gexA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.61 | 55.0 | 5.18e-01 | 98.4% | 82.2% |
| 2ch9A01 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.61 | 49.0 | 5.09e-01 | 100.0% | 92.9% |
| 4puxA00 | 2.40.160.20 | Mainly Beta › Beta Barrel › Porin › | 0.60 | 42.0 | 3.88e-01 | 100.0% | 56.7% |
| 3gzbA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.59 | 53.0 | 4.94e-01 | 98.4% | 81.2% |
| 2k4nA00 | 3.30.720.70 | Alpha Beta › 2-Layer Sandwich › Signal recognition particle alu RNA binding heterodimer, srp9/1 › | 0.56 | 35.0 | 3.67e-01 | 77.4% | 69.4% |
| 3icyA00 | 3.30.450.20 | Alpha Beta › 2-Layer Sandwich › Beta-Lactamase › PAS domain | 0.56 | 36.0 | 3.67e-01 | 83.9% | 66.1% |
| 4rlcA00 | 2.40.160.20 | Mainly Beta › Beta Barrel › Porin › | 0.52 | 44.0 | 4.33e-01 | 98.4% | 84.4% |
| 3bwlB00 | 3.30.450.20 | Alpha Beta › 2-Layer Sandwich › Beta-Lactamase › PAS domain | 0.52 | 36.0 | 3.71e-01 | 96.0% | 74.0% |
ECOD (27)
| UID | F-ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 4254866 | 243.1.1.66 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › TcaA_5th | 0.74 | 69.0 | 6.89e-01 | 100.0% | 97.6% |
| 3615602 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.73 | 68.0 | 6.12e-01 | 100.0% | 91.5% |
| 3595171 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.71 | 65.0 | 5.26e-01 | 99.2% | 89.1% |
| 4419521 | 243.1.1.108 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2_YvbJ | 0.71 | 66.0 | 6.39e-01 | 98.4% | 97.0% |
| 3856363 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.70 | 64.0 | 5.70e-01 | 100.0% | 94.3% |
| 3716842 | 243.1.1.86 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2_MEX67 | 0.69 | 48.0 | 4.26e-01 | 70.2% | 61.2% |
| 1282324 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.69 | 64.0 | 6.26e-01 | 99.2% | 94.0% |
| 3189800 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.69 | 63.0 | 5.99e-01 | 99.2% | 97.9% |
| 3407575 | 243.1.1.40 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NXF_NTF2 | 0.69 | 63.0 | 5.28e-01 | 100.0% | 85.7% |
| 3021721 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.68 | 62.0 | 4.92e-01 | 98.4% | 59.8% |
| 3281675 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.67 | 54.0 | 5.80e-01 | 87.1% | 100.0% |
| 3216011 | 243.1.1.109 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF5382, DUF5382_C | 0.66 | 60.0 | 4.47e-01 | 98.4% | 44.4% |
| 3541003 | 243.3.1.1 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cystatin | 0.66 | 51.0 | 5.43e-01 | 100.0% | 93.5% |
| 3524310 | 243.3.1.1 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cystatin | 0.65 | 51.0 | 5.36e-01 | 100.0% | 92.7% |
| 3425035 | 243.1.1.122 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF28340 | 0.65 | 48.0 | 5.35e-01 | 95.2% | 96.0% |
| 3372143 | 881.1.1.1 ↗ | a+b three layers › Mog1p/PsbP-like › Mog1p/PsbP-like › Mog1p/PsbP-like › PsbP | 0.64 | 47.0 | 4.70e-01 | 96.8% | 75.2% |
| 3853362 | 243.3.1.2 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cathelicidins | 0.63 | 46.0 | 4.79e-01 | 95.2% | 80.9% |
| 3542721 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.63 | 46.0 | 4.75e-01 | 96.8% | 80.0% |
| 3895474 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.62 | 49.0 | 5.07e-01 | 98.4% | 88.7% |
| 3885513 | 243.1.1.49 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF2358 | 0.62 | 55.0 | 5.04e-01 | 98.4% | 80.5% |
| 3810779 | 243.3.1.45 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › TIN1 | 0.59 | 47.0 | 5.12e-01 | 93.5% | 99.0% |
| 3220280 | 243.3.1.1 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cystatin | 0.59 | 48.0 | 5.02e-01 | 100.0% | 97.3% |
| 3217156 | 243.1.1.46 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF5382 | 0.59 | 52.0 | 5.03e-01 | 96.8% | 94.3% |
| 3660451 | 243.3.1.45 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › TIN1 | 0.58 | 48.0 | 5.09e-01 | 91.9% | 96.4% |
| 3623742 | 206.1.1.20 ↗ | a+b complex topology › Protein kinase/SAICAR synthase/ATP-grasp › Protein kinase/SAICAR synthase/ATP-grasp › Protein kinase › PK_Tyr_Ser-Thr | 0.51 | 39.0 | 2.85e-01 | 80.6% | 35.6% |
| 4353273 | 331.9.1.10 ↗ | a+b two layers › TBP-like › Subdomain of clathrin and coatomer appendage domain › Subdomain of clathrin and coatomer appendage domain › PF28631 | 0.51 | 33.0 | 3.12e-01 | 96.0% | 54.0% |
| 3922973 | 206.1.1.20 ↗ | a+b complex topology › Protein kinase/SAICAR synthase/ATP-grasp › Protein kinase/SAICAR synthase/ATP-grasp › Protein kinase › PK_Tyr_Ser-Thr | 0.51 | 38.0 | 2.85e-01 | 79.8% | 32.5% |